CPT code 88235 covers the laboratory preparation of tissue cultures from amniotic fluid or chorionic villus cells for nonneoplastic chromosome analysis. This cytogenetic preparatory step is a critical component of prenatal diagnostic workflows, enabling subsequent karyotyping or chromosomal testing that can detect chromosomal abnormalities in the fetus. Nationally, such laboratory services support prenatal care pathways and genetic diagnostic programs across hospitals and reference laboratories.

Key payers in typical analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context and service expectations for CPT code 88235, along with what to expect from payer coverage policies and benchmarking considerations where available. The publication outlines typical sites of service and the role of this cytogenetic procedure in prenatal diagnosis, and it signals areas where policy updates or payer requirements most commonly affect billing and documentation.

The content is intended to help laboratory managers, billing professionals, and policy analysts understand the clinical purpose of CPT code 88235, common billing scenarios, and the types of payer policies that typically govern coverage and reimbursement for prenatal tissue culture services.